glp-1 review What Happens After Weight Loss? New research is taking a

Tirzepatide (Mounjaro, Zepbound) activates two: GLP-1 and GIP

A., Kind J., Kthe L

January 2017 Volume 40, Supplement 1

[(accessed on 12 March 2024)];Curr

Common adverse effects include: Gastrointestinal symptoms nausea, vomiting, diarrhoea, constipation, and abdominal pain (affecting up to 40% of users) Reduced appetite and weight loss Injection site reactions redness, itching, or discomfort Hypoglycaemia particularly when used alongside insulin or sulfonylureas More serious but rare adverse effects include pancreatitis (inflammation of the pancreas) and gallbladder disease

On phentermine, the reduced appetite is non-specific, you simply eat less